Fresenius Medical Care Stock Filter Stocks by Fundamentals
| FME Stock | EUR 46.00 0.53 1.14% |
Fundamental analysis of Fresenius Medical allows traders to better anticipate movements in Fresenius Medical's stock price by examining its financial health and performance throughout various phases of its business cycle.
Fresenius |
Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
Fresenius Fundamentals
| Return On Equity | 0.0608 | |||
| Return On Asset | 0.0277 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 21.59 B | |||
| Shares Outstanding | 293.41 M | |||
| Shares Owned By Insiders | 32.16 % | |||
| Shares Owned By Institutions | 38.61 % | |||
| Price To Earning | 15.86 X | |||
| Price To Book | 0.59 X | |||
| Price To Sales | 0.46 X | |||
| Revenue | 19.4 B | |||
| Gross Profit | 5.31 B | |||
| EBITDA | 3.42 B | |||
| Net Income | 673.4 M | |||
| Cash And Equivalents | 922 M | |||
| Cash Per Share | 3.04 X | |||
| Total Debt | 7.17 B | |||
| Debt To Equity | 104.70 % | |||
| Current Ratio | 0.99 X | |||
| Book Value Per Share | 47.68 X | |||
| Cash Flow From Operations | 2.17 B | |||
| Earnings Per Share | 2.22 X | |||
| Price To Earnings To Growth | 1.05 X | |||
| Number Of Employees | 128.04 K | |||
| Beta | 0.9 | |||
| Market Capitalization | 10.47 B | |||
| Total Asset | 35.75 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 1.19 % | |||
| Net Asset | 35.75 B | |||
| Last Dividend Paid | 1.12 |
About Fresenius Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fresenius Medical Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fresenius Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fresenius Medical Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Fresenius Stock
When determining whether Fresenius Medical Care is a strong investment it is important to analyze Fresenius Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Fresenius Medical's future performance. For an informed investment choice regarding Fresenius Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.